Free access for registered Healthcare Professionals and home of "The Oncology Podcast"
Join us today for the latest oncology news, commentary, educational resources and podcasts
oncologynetwork.com.au
@craigunderhill.bsky.social + Rachael Babin discuss #vorasidenib, #selpercatinib and #tafasitamab. Shout out to Jim Whittle, Katy Peters & #ArchieGoodwyn #glioma #lymphoma #thyroidcancer #IDH @dukecancer.bsky.social @petermaccc.bsky.social Listen now: t.ly/jkDnJ
@craigunderhill.bsky.social + Rachael Babin discuss #vorasidenib, #selpercatinib and #tafasitamab. Shout out to Jim Whittle, Katy Peters & #ArchieGoodwyn #glioma #lymphoma #thyroidcancer #IDH @dukecancer.bsky.social @petermaccc.bsky.social Listen now: t.ly/jkDnJ
We explore PERISCOPE II, NeoSUMMIT-01 and whether it's time to rethink the traditional curative vs palliative framework in modern oncology | Listen: t.ly/g5RAT
#Oncology #Podcast #MedEd #OncologyJournalClub #Cancer #CanSky #MedSky #OncSky @craigunderhill.bsky.social
We explore PERISCOPE II, NeoSUMMIT-01 and whether it's time to rethink the traditional curative vs palliative framework in modern oncology | Listen: t.ly/g5RAT
#Oncology #Podcast #MedEd #OncologyJournalClub #Cancer #CanSky #MedSky #OncSky @craigunderhill.bsky.social
✔️ Early molecular testing
✔️ Hyperphosphataemia & mucositis
✔️ Nail, skin & eye toxicities
✔️ And much more...
Listen now: t.ly/kjU3b
✔️ Early molecular testing
✔️ Hyperphosphataemia & mucositis
✔️ Nail, skin & eye toxicities
✔️ And much more...
Listen now: t.ly/kjU3b
In Episode 1, Prof Nick Pavlakis and Prof John Bridgewater explore how molecular profiling and targeted therapies are reshaping the management of intrahepatic cholangiocarcinoma.
🎧 Listen now: t.ly/bEvfI
#iCCA #Cholangiocarcinoma #PrecisionOncology #MedEd
In Episode 1, Prof Nick Pavlakis and Prof John Bridgewater explore how molecular profiling and targeted therapies are reshaping the management of intrahepatic cholangiocarcinoma.
🎧 Listen now: t.ly/bEvfI
#iCCA #Cholangiocarcinoma #PrecisionOncology #MedEd
The #OJC dive into the plenary studies from #ASCO2026 in Part 1: t.ly/V_SqO
#Oncology #CanSky #OncSky #OncologyPodcast @ascocancer.bsky.social @craigunderhill.bsky.social
The #OJC dive into the plenary studies from #ASCO2026 in Part 1: t.ly/V_SqO
#Oncology #CanSky #OncSky #OncologyPodcast @ascocancer.bsky.social @craigunderhill.bsky.social
P.S. be prepared for karaoke! #ASCO2026 @ascocancer.bsky.social
P.S. be prepared for karaoke! #ASCO2026 @ascocancer.bsky.social
Cellular therapies are moving beyond blood cancers. We cover a new paper in npj Precision Oncology highlighting why institutional readiness is just as important as scientific breakthroughs | t.ly/VvUPp
Cellular therapies are moving beyond blood cancers. We cover a new paper in npj Precision Oncology highlighting why institutional readiness is just as important as scientific breakthroughs | t.ly/VvUPp
HCPs can listen now 👇t.ly/RZWKz
#Oncology #Cholangiocarcinoma #PrecisionMedicine #IDH1 #TACE #SIRT #InterventionalRadiology #GICancer
HCPs can listen now 👇t.ly/RZWKz
#Oncology #Cholangiocarcinoma #PrecisionMedicine #IDH1 #TACE #SIRT #InterventionalRadiology #GICancer
Promising signals—but what actually changes practice? Thanks to @craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson | Listen: t.ly/a_hTM #Oncology #MedSky # OncSky MedEd #CancerResearch #CME #OncologyJournalClubPodcast
Promising signals—but what actually changes practice? Thanks to @craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson | Listen: t.ly/a_hTM #Oncology #MedSky # OncSky MedEd #CancerResearch #CME #OncologyJournalClubPodcast
In our latest podcast, we explore the case for early molecular testing and the role of the MDT in expanding treatment options | 🎧 Listen: t.ly/J_Wv2
#oncology #MedEd #BTC #BillaryTractCancers #OncSky
In our latest podcast, we explore the case for early molecular testing and the role of the MDT in expanding treatment options | 🎧 Listen: t.ly/J_Wv2
#oncology #MedEd #BTC #BillaryTractCancers #OncSky
The Oncology Journal Club Podcast is back! With the same thoughtful analysis from
@craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson. Ep 1 is a big one! Hot Flushes, Aspirin + AI. 🎧 Listen now > t.ly/amo1W #OJC #CancerResearch #OncologyPodcast #MedEd
The Oncology Journal Club Podcast is back! With the same thoughtful analysis from
@craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson. Ep 1 is a big one! Hot Flushes, Aspirin + AI. 🎧 Listen now > t.ly/amo1W #OJC #CancerResearch #OncologyPodcast #MedEd
Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
#LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky
Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
#LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky